Reduction in the toxicity of a component of an artificial blood substitute by supercritical fluid fractionation

Transfusion

Volumn 28, Issue 4, 1988, Pages 375-378

  Krukonis, V ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL BLOOD; BLOOD SUBSTITUTE; POLOXAMER;

CELL CULTURE; CHEMOTAXIS; GRANULOCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TOXICITY;

ANIMAL; BLOOD SUBSTITUTES; CHEMICAL FRACTIONATION; DRUG COMBINATIONS; FLUOROCARBONS; HELA CELLS; HUMAN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023682127     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1988.28488265271.x     Document Type: Article

References (25)

1. Clinical studies of a perfluorochemical whole blood substitute (Fluosol‐DA): summary of 186 cases
2. Artificial blood emulsifiers
3. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis
4. Effect of perfluorochemical blood substitutes on human neutrophil function
5. Paralysis of phagocyte migration due to an artificial blood substitute
6. Increased infection mortality and decreased neutrophil migration due to a component of an artificial blood substitute
7. Effect of exchange transfusion with an oxygen‐carrying resuscitation fluid on the efficacy of penicillin therapy of pneumococcal infection in rats
8. Cytotoxicity of a perfluorocarbon blood substitute to macrophages in vitro
9. Changes in human cultured cells exposed to a perfluorocarbon emulsion
10. Polyalkylene oxide block copolymers
11. Phase equilibria in systems with ethylene above its critical temperature
12. Xenon as a supercritical solvent
13. Supercritical fluid processing of polymers
14. Metastasis results from preexisting variant cells within a malignant tumor
15. Adherence of stored granulocytes to vascular endothelium and extracellular matrix (abstract)
16. Variation in toxicity of Escherichia coli endotoxin after treatment with perfluorated blood substitutes in mice
17. Perfluorocarbon enhancement of heterologous red cell survival: a reticuloendothelial block effect
18. Applications of pluronic polyols in the cosmetic industry
19. FIuosol‐DA as a red‐cell substitute in acute anemia
20. Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results
21. Effect of Fluosol‐DA on infarct morphology and vulnerability to ventricular arrhythmia
22. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion
23. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs